Effectiveness of Ezetimibe in Reducing the Estimated Risk for Fatal Cardiovascular Events in Hypercholesterolaemic Patients with Inadequate Lipid Control While on Statin Monotherapy as Measured by the SCORE Model

Objectives. The aim of this prospective cohort, multicentre study was to assess the effect of coadministrating ezetimibe 10 mg/day with an ongoing statin on the estimated risk for Cardiovascular (CVD) mortality in patients with persistently elevated LDL-C after statin monotherapy. Methods. The Syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampalis, John S., Bissonnette, Stéphane, Boukas, Stella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169312/
https://www.ncbi.nlm.nih.gov/pubmed/21991439
http://dx.doi.org/10.4061/2011/597163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169312/
https://www.ncbi.nlm.nih.gov/pubmed/21991439
http://dx.doi.org/10.4061/2011/597163

Ejemplares similares